معرفی
Professor Paul Scuffham is a globally recognized health economist at Griffith University’s School of MDP - Clinical Medicine. He has led groundbreaking research in cost-benefit analysis, economic evaluation of healthcare interventions, and health policy translation, with over 450 peer-reviewed publications and 17,500 citations. As founding Director of the Centre for Applied Health Economics (2008–2019) and former Director of the Menzies Health Institute Queensland (2018–2024), he has shaped research agendas across comorbid conditions, telehealth, and priority setting.
- Key Roles: Director, Menzies Health Institute Queensland (2018–2024); Chair, ISPOR Asia Consortium (2022–2024); Fellow, Australian Academy of Health and Medical Sciences (2016–).
- Education: PhD in Economics (University of Otago); Postgraduate Diploma in Economics (University of Otago); BA in Economics (University of Otago).
Research Focus: Scuffham specializes in identifying cost-effective healthcare solutions using Markov modeling and discrete choice experiments. His work spans behavioral interventions, pharmaceuticals, medical devices, imaging, and telemedicine, with a focus on policy implementation. Notable projects include optimizing bariatric surgery access for Queensland and evaluating large-scale clinical trials involving over 45,000 and 70,000 participants.
Scientific Recognition:
- Top 1% of global scientists (Stanford-Elsevier)
- Board member, Australian Academy of Health and Medical Sciences (2022–)
- International advisory role to Ministry of Health, Singapore (2016–2018)
Grants & Leadership: Scuffham has led over 89 funded research projects, including NHMRC grants for AI in medical imaging, wound care, and cardiovascular disease management. His team has influenced policy through citizen juries and preference studies, with grants totaling millions of dollars in health economics research.
